Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen

Vaccine

Volumn 29, Issue 16, 2011, Pages 3074-3082

  Franceschi, Valentina ^a   Capocefalo, Antonio ^a   Calvo Pinilla, Eva ^b   Redaelli, Marco ^c   Mucignat Caretta, Carla ^c   Mertens, Peter ^d   Ortego, Javier ^b   Donofrio, Gaetano ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^c UNIVERSITY OF PADOVA   (Italy)

^d INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Bovine herpesvirus 4; BTV; Viral vector; VP2

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; PROTEIN VP2; VIRUS VECTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BLUETONGUE; BLUETONGUE ORBIVIRUS; BOVINE HERPESVIRUS 4; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIREMIA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BASE SEQUENCE; BLUETONGUE; BLUETONGUE VIRUS; CAPSID PROTEINS; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DOGS; GENETIC VECTORS; HERPESVIRUS 4, BOVINE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PILOT PROJECTS; PLAQUE ASSAY; RECEPTOR, INTERFERON ALPHA-BETA; VIRAL VACCINES; VIREMIA;

EID: 79953210676     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.075     Document Type: Article

References (31)

1. Maclachlan N.J., Drew C.P., Darpel K.E., Worwa G. The pathology and pathogenesis of bluetongue. Journal of Comparative Pathology 2009, 141(July (1)):1-16.
2. Mellor P.S., Boorman J., Baylis M. Culicoides biting midges: their role as arbovirus vectors. Annual Review of Entomology 2000, 45:307-340.
3. Hofmann M.A., Renzullo S., Mader M., Chaignat V., Worwa G., Thuer B. Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerging Infectious Diseases 2008, 14(December (12)):1855-1861.
4. Barros S.C., Ramos F., Luis T.M., Vaz A., Duarte M., Henriques M., et al. Molecular epidemiology of bluetongue virus in Portugal during 2004-2006 outbreak. Veterinary Microbiology 2007, 124(September (1-2)):25-34.
5. Worwa G., Hilbe M., Ehrensperger F., Chaignat V., Hofmann M.A., Griot C., et al. Experimental transplacental infection of sheep with bluetongue virus serotype 8. The Veterinary Record 2009, 164(April (16)):499-500.
6. Calvo-Pinilla E., Nieto J.M., Ortego J. Experimental oral infection of bluetongue virus serotype 8 in type I interferon receptor-deficient mice. The Journal of General Virology 2010, 91(November (Pt 11)):2821-2825.
7. Mertens P.P., Brown F., Sangar D.V. Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology 1984, 135(May (1)):207-217.
8. DeMaula C.D., Bonneau K.R., MacLachlan N.J. Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies. Virus Research 2000, 67(March (1)):59-66.
9. Roy P., Boyce M., Noad R. Prospects for improved bluetongue vaccines. Nature Reviews 2009, 7(February (2)):120-128.
10. Savini G., MacLachlan N.J., Sanchez-Vizcaino J.M., Zientara S. Vaccines against bluetongue in Europe. Comparative Immunology, Microbiology and Infectious Diseases 2008, 31(March (2-3)):101-120.
11. Lobato Z.I., Coupar B.E., Gray C.P., Lunt R., Andrew M.E. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Veterinary Immunology and Immunopathology 1997, 59(November (3-4)):293-309.
12. Wade-Evans A.M., Pullen L., Hamblin C., O'Hara R., Burroughs J.N., Mertens P.P. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge. The Journal of General Virology 1997, 78(July (Pt 7)):1611-1616.
13. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 2007, 25(January (4)):672-678.
14. Calvo-Pinilla E., Rodriguez-Calvo T., Anguita J., Sevilla N., Ortego J. Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PloS One 2009, 4(4):e5171.
15. Calvo-Pinilla E., Rodriguez-Calvo T., Sevilla N., Ortego J. Heterologous prime-boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection. Vaccine 2009, 28(December (2)):437-445.
16. Jameson P., Schoenherr C.K., Grossberg S.E. Bluetongue virus, an exceptionally potent interferon inducer in mice. Infection and Immunity 1978, 20(April (1)):321-323.
17. Donofrio G., Cavirani S., Simone T., van Santen V.L. Potential of bovine herpesvirus 4 as a gene delivery vector. Journal of Virological Methods 2002, 101(March (1-2)):49-61.
18. Donofrio G., Franceschi V., Capocefalo A., Cavirani S., Sheldon I.M. Isolation and characterization of bovine herpesvirus 4 (BoHV-4) from a cow affected by post partum metritis and cloning of the genome as a bacterial artificial chromosome. Reproductive Biology and Endocrinology 2009, 7:83.
19. Donofrio G., Franceschi V., Capocefalo A., Taddei S., Sartori C., Bonomini S., et al. Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development. Clinical and Vaccine Immunology 2009, 16(November (11)):1675-1686.
20. Donofrio G., Bottarelli E., Sandro C., Flammini C.F. Expression of bovine viral diarrhea virus glycoprotein E2 as a soluble secreted form in a Mammalian cell line. Clinical and Vaccine Immunology 2006, 13(June (6)):698-701.
21. Donofrio G., Sartori C., Franceschi V., Capocefalo A., Cavirani S., Taddei S., et al. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD. Vaccine 2008, 26(November (48)):6031-6042.
22. Toussaint J.F., Sailleau C., Breard E., Zientara S., De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. Journal of virological methods 2007, 140(March (1-2)):115-123.
23. Gillet L., Schroeder H., Mast J., Thirion M., Renauld J.C., Dewals B., et al. Anchoring tick salivary anti-complement proteins IRAC I and IRAC II to membrane increases their immunogenicity. Veterinary Research 2009, 40(September-October (5)):51.
24. Donofrio G., Ravanetti L., Cavirani S., Herath S., Capocefalo A., Sheldon I.M. Bacterial infection of endometrial stromal cells influences bovine herpesvirus 4 immediate early gene activation: a new insight into bacterial and viral interaction for uterine disease. Reproduction 2008, 136(September (3)):361-366.
25. Donofrio G., Cavaggioni A., Bondi M., Cavirani S., Flammini C.F., Mucignat-Caretta C. Outcome of bovine herpesvirus 4 infection following direct viral injection in the lateral ventricle of the mouse brain. Microbes and Infection 2006, 8(March (3)):898-904.
26. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., et al. Functional role of type I and type II interferons in antiviral defense. Science (New York, NY) 1994, 264(June (5167)):1918-1921.
27. Gillet L., Dewals B., Farnir F., de Leval L., Vanderplasschen A. Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. Cancer Research 2005, 65(October (20)):9463-9472.
28. Thirion M., Machiels B., Farnir F., Donofrio G., Gillet L., Dewals B., et al. Bovine herpesvirus 4 ORF73 is dispensable for virus growth in vitro, but is essential for virus persistence in vivo. The Journal of General Virology 2010, 91(October (Pt 10)):2574-2584.
29. Franceschi V., Capocefalo A., Ravanetti L., Vanderplasschen A., Gillet L., Cavirani S., et al. Bovine herpesvirus 4 immediate early 2 (Rta) gene is an essential gene and is duplicated in bovine herpesvirus 4 isolate U. Veterinary Microbiology 2010.
30. Burton E.A., Fink D.J., Glorioso J.C. Gene delivery using herpes simplex virus vectors. DNA and Cell Biology 2002, 21(December (12)):915-936.
31. MacKenzie-Graham A., Boline J., Toga A.W. Brain atlases and neuroanatomic imaging. Methods Mol Biol. 2007, 401:183-194. Review.